| Chronic Fatigue Syndrome |
1 |
1 |
| Pain Management |
0 |
0.52 |
| COVID-19 |
0 |
0.99 |
| Pain |
0 |
0.43 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.43 |
| Fatigue |
0 |
0.38 |
| Neuropathic Pain |
0 |
0.37 |
| Chronic Pain |
0 |
0.34 |
| Complex Regional Pain Syndrome |
0 |
0.34 |
| Limb Pain |
0 |
0.33 |
| Acute Pain |
0 |
0.31 |
| Vagus Nerve Stimulation |
0 |
0.3 |
| Nerve |
0 |
0.28 |
| Otolaryngology |
0 |
0.25 |
| Exercise |
0 |
0.24 |
| Fibromyalgia |
0 |
0.24 |
| Transcutaneous Electrical Nerve Stimulation |
0 |
0.23 |
| Adverse Effects |
0 |
0.19 |
| Brain |
0 |
0.19 |
| Ganglion |
0 |
0.19 |
| Arrhythmia |
0 |
0.18 |
| Patient Safety |
0 |
0.17 |
| Ear |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Antioxidant |
0 |
0.1 |
| Artery |
0 |
0.1 |
| Generics |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Limb |
0 |
0.1 |
| Massachusetts |
0 |
0.1 |
| Muscle |
0 |
0.1 |
| Orthostatic Intolerance |
0 |
0.1 |
| UK Site Content |
0 |
0.1 |
| Ultrasonography |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.08 |
| Biologic Therapy |
0 |
0.07 |
| Headache |
0 |
0.07 |
| Hyperhidrosis |
0 |
0.07 |
| Local Anesthetic |
0 |
0.07 |
| Memory Problems |
0 |
0.07 |
| Migraine |
0 |
0.07 |
| Asthma |
0 |
0.06 |
| Acetylcholinesterase Inhibitor |
0 |
0.05 |
| Alaska |
0 |
0.05 |
| Anesthesia |
0 |
0.05 |
| Antibacterial Agents |
0 |
0.05 |
| Antiviral Agents |
0 |
0.05 |
| Anxiety |
0 |
0.05 |
| Autonomic Nervous System |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Cervical Region |
0 |
0.05 |
| Clinical Guidelines |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Cognition |
0 |
0.05 |
| Cough |
0 |
0.05 |
| Dizziness |
0 |
0.05 |
| Dyspepsia |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Fluoroscopy |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Hypotension |
0 |
0.05 |
| Inhalers |
0 |
0.05 |
| Insomnia |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Memory |
0 |
0.05 |
| Raynaud Disease |
0 |
0.05 |
| Refractory |
0 |
0.05 |
| Sleep |
0 |
0.05 |
| Social Media |
0 |
0.05 |
| Tachycardia |
0 |
0.05 |
| Vein |
0 |
0.05 |
| Viral Infection |
0 |
0.05 |
| Weakness |
0 |
0.05 |
| Anxiety Disorder |
0 |
0.03 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.03 |
| Constipation |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Gastroesophageal Reflux Disease |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Herpes Zoster |
0 |
0.03 |
| Muscular Atrophy |
0 |
0.03 |
| Myasthenia Gravis |
0 |
0.03 |
| Post-Traumatic Stress Disorder |
0 |
0.03 |
| Sleep Disorders |
0 |
0.03 |